reported that ST3GAL4 recombinant protein extracted from a melanoma library showed enzymatic activity towards both type I and type II disaccharides in in vitro assays whereas preferentially catalyzed type II substrates in in vivo condition (53). Here, ST3GAL4 is linked to melanoma.